---
title: Pulmonology & Critical Care
icon: material/lungs
author: J. Austin Straley, DO
date: 2024-03-16
permalink: /pccm
categories:
    - Pulmonology
    - Critical Care
---
- Acute Respiratory Failure
    - [Noninvasive Ventilation for ARF](https://www.thoracic.org/statements/resources/cc/niv-guidelines.pdf)
- ARDS
    - [Mechanical Ventilation in ARDS](https://pubmed.ncbi.nlm.nih.gov/28459336/){:target="_blank"}
    - [ACURASYS: Neuromuscular blockade in 1st 48hrs reduced 28- and 90-day mortality](https://pubmed.ncbi.nlm.nih.gov/20843245/){:target="_blank"}
    - [PROSEVA: Proning in severe ARDS reduced 28- and 90-day mortality](https://pubmed.ncbi.nlm.nih.gov/23688302/){:target="_blank"}
- Asthma
    - [Novel START: Prn Budesonide+formoterol reduced risk of exacerbations vs. Albuterol](https://pubmed.ncbi.nlm.nih.gov/31112386/){:target="_blank"}
    - [AMAZES: Azithromycin reduced rate of asthma exacerbations, improved QOL in severe](https://pubmed.ncbi.nlm.nih.gov/28687413/){:target="_blank"}
- COPD
    - Treatment
        - Antibiotics
        - [AECOPD](https://pubmed.ncbi.nlm.nih.gov/18321904/){:target="_blank"}
            - [REDUCE: 5d is non-inferior to 14d for prevention of re-AECOPD](http://www.ncbi.nlm.nih.gov/pubmed/23695200/)
        - [Pharmacotherapy](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193862/)
            - [FLAME: LABA + LAMA > LABA + ICS if mMRC ≥2 for exacerbations](http://www.ncbi.nlm.nih.gov/pubmed/27181606/)
            - [UPLIFT: Tiotropium associated with improvements in lung function, QOL, and exacerbations during 4-year period; did not reduce rate of FEV1 decline](https://www.nejm.org/doi/full/10.1056/nejmoa0805800)
- ICU
    - [EMCRIT: Fluids/Electrolytes](https://emcrit.org/ibcc/toc/#nephrology/)
    - [3SITES: Subclavian less CLABSIs and DVTs than jugular/femoral, more PTX](https://pubmed.ncbi.nlm.nih.gov/26398070/){:target="_blank"}
    - [65: MAP target 60-65 in pts ≥65 did not have mortality difference in vasodilatory shock](https://pubmed.ncbi.nlm.nih.gov/32049269/){:target="_blank"}
    - [Routine vs. On-Demand CXR in MV pts in the ICU increases use 34%, no benefit](https://pubmed.ncbi.nlm.nih.gov/19896184/){:target="_blank"}
    - [LACTATE: Decreased in-hospital mortality and shorter ICU stay with aim of 20% reduction q2hrs for the first 8 hours in ICU; guided group received more fluids and started vasopressors earlier but did not have faster rate of reduction in lactate](https://pubmed.ncbi.nlm.nih.gov/20463176/){:target="_blank"}
    - [PRORATA: <10% increase in mortality at 30-60 days with procalcitonin-guided ABX](https://pubmed.ncbi.nlm.nih.gov/20097417/){:target="_blank"}
    - [SPICE-III: Precedex had more ADE w/o improving mortality as primary sedative in MV](https://pubmed.ncbi.nlm.nih.gov/31112380/){:target="_blank"}
    - [SOAP-II: Dopamine = NE for 1st line; Dopamine has increased risk of arrhythmias](https://pubmed.ncbi.nlm.nih.gov/20200382/){:target="_blank"}
    - Septic Shock
        - [Surviving Sepsis Campaign](https://pubmed.ncbi.nlm.nih.gov/18158437/){:target="_blank"}
- Interstitial Lung Disease (ILD)
    - [IPF](https://pubmed.ncbi.nlm.nih.gov/30168753/){:target="_blank"}
    - [Sarcoidosis](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159433/)
- Lung Cancer
    - [National Lung Cancer Screening Trial](https://www.nejm.org/doi/full/10.1056/NEJMoa1102873)
    - [Early Palliative care in metastatic NSCLC improves QOL and improved survival](https://pubmed.ncbi.nlm.nih.gov/20818875/){:target="_blank"}
- Pleural Effusion
    - [Lights Criteria for Pleural Effusions](https://www.acpjournals.org/doi/10.7326/0003-4819-77-4-507)
    - Management
        - [Management of infectious processes of the pleural space: a review](https://pubmed.ncbi.nlm.nih.gov/22536502/){:target="_blank"}
        - [Malignant Pleural Effusions](https://pubmed.ncbi.nlm.nih.gov/30272503/){:target="_blank"}
- Sleep Apnea
    - [Evaluation and Management of Obesity Hypoventilation Syndrome](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680300/)

## Resources

- [EMCrit IBCC][1]
- [CXR Atlas][2]

[1]: https://emcrit.org/ibcc/toc/
[2]: https://www.meddean.luc.edu/lumen/meded/medicine/pulmonar/cxr/atlas/cxratlas_f.htm
